Spry2-mediated inhibition of the Ras/ERK pathway through interaction with Src kinase following cerebral ischemia

Brain Injury

Volumn 22, Issue 3, 2008, Pages 275-281

  Wu, Huiwen ^a   Li, Hongfu ^b   Guo, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Province Hospital on Integration of Chinese and Western Medicine   (China)

Author keywords

Cerebral ischemia; ERKs; Phosphorylation; Ras; Spry2; Src family tyrosine kinases

Indexed keywords

KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAF PROTEIN; RAS PROTEIN; SPROUTY PROTEIN; SPROUTY PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 39749116780     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050801911295     Document Type: Article

References (24)